Abstract
Concern has been expressed about the rapid increase in the incidence of esophageal carcinoma in the United States. This rise is due to an increase in the number of cases of adenocarcinoma of the esophagus. Because of the relatively small number of cases of esophageal carcinoma, the absolute risk of developing this cancer in the United States remains small. Potential origins for this increase in esophageal adenocarcinoma are examined in this review, including the risk induced by obesity, low dietary antioxidants, high dietary fat, family history of breast cancer, smoking, gastroesophageal reflux, and Barrett’s esophagus. The risk of esophageal adenocarcinoma is inversely associated with infection by Helicobacter pylori organisms. A better understanding of risk factors involved in the increased incidence of esophageal adenocarcinoma is important for development of new preventive strategies for this serious disorder.
Similar content being viewed by others
References
HofstetterW, Swisher SG, Correa AM, et al.: Treatment outcomes of resected esophageal cancer. Ann Surg 2002, 236:376–384. Important description of survival rates for esophageal carcinoma in the United States following surgical esophagectomy.
WHO mortality database. http://www.who.int/whosis/whsa
El-Serag HB, Mason AC, Petersen J, Key CR: Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002, 50:368–372.
Vega KJ, Jamal MM: Changing pattern of esophageal cancer incidence in New Mexico. Am J Gastroenterol 2000, 95:2352–2356.
Vizcaino AP, Moreno V, Lambert R, Parkin DM: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 2002, 99:860–868.
Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH:Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001, 92:549–555.
Powell J, McConkey CC, Gillison EW, Spychal RT: Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002, 102:422–427.
Walther C, Zilling T, Perfekt R, Moller T: Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997. Eur J Surg 2001, 167:748–757.
Brown LM, Devesa SS: Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002, 11:235–256.
Brown LM, Hoover R, Silverman D, et al.: Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001, 153:114–122.
Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002, 288:1723–1727.
Mokdad AH, Serdula MK, Dietz WH, et al.: The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999, 282:1519–1522. Important description of the obesity epidemic in the United States.
Kottke TE, Clark MM, Aase LA, et al.: Self-reported weight, weight goals, and weight control strategies of a midwestern population. Mayo Clinic Proc 2002, 77:114–121.
WuAH, Wan P, Bernstein L: A multiethnic population-based study of smoking, alcohol, and body size and risk of adenocarcinoma of the stomach and esophagus (United States). Cancer Causes Control 2001, 12:721–732. Identifies major risk factors for the development of adenocarcinoma.
Chen H, Ward MH, Graubard BI, et al.: Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr 2002, 75:137–144.
Mayne ST, Risch HA, Dubrow R, et al.: Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001, 10:1055–1062.
Mark SD, Qiao YL, Dawsey SM, et al.: Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000, 92:1753–1763.
Dhillon PK, Farrow DC, Vaughan TL, et al.: Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001, 93:148–152.
Henrik-Siman J, Forsgren A, Berglund G, Floren CH: Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter 2001, 6:310–316.
Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999, 340:825–831. Major study identifying gastroesophageal reflux as an important risk factor for the development of esophageal adenocarcinoma.
SpechlerSJ, Lee E, Ahnen D, et al.: Long-term outcome of medical surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001, 285:2331–2338. This large multicenter study shows no evidence that surgical treatment for gastroesophageal reflux can reduce the risk of dying from esophageal carcinoma.
Conio M, Cameron AJ, Romero Y, et al.: Secular trends in the epidemiology and outcome of Barrett’s oesophagus in Olmsted County, Minnesota. Gut 2001, 48:304–309.
GersonLB, Shetler K, Triadafilopoulos G: Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 2002, 123:461–467. This study shows that the prevalence of Barrett’s esophagus may be much higher than expected in older white American men.
Bytzer P, Christensen PB, Damkier P, et al.: Adenocarcinoma of the esophagus and Barrett’s esophagus: a population-based study. Am J Gastroenterol 1999, 94:86–91.
Corley DA, Levin TR, Habel LA, et al.: Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology 2002, 122:633–640.
FergusonMK, Durkin A: Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 2002, 6:29–35. This study provides evidence that upper endoscopic surveillance of patients with Barrett’s esophagus may improve their survival rates.
Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A: Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett’s esophagus. Surg Endosc 2002, 16:263–266.
Koch TR, Yuan LX, Petro A, Opara EC: Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion. Dig Dis Sci 2002, 47:2486–2492.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koch, T.R. The changing face of esophageal malignancy. Curr Gastroenterol Rep 5, 187–191 (2003). https://doi.org/10.1007/s11894-003-0018-6
Issue Date:
DOI: https://doi.org/10.1007/s11894-003-0018-6